Catalyst Wire Dossier Catalyst Wire Dossier

ZURNAI

Nalmefene hydrochloride · Purdue Pharma L.P.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZURNAI, covering 2024-08-07 to 2024-08-07. Get the full timeline:

Most recent: FDA Approved: ZURNAI — Original Application (Purdue Pharma L.P.)

See pricing